title: Characterization of an essential arginine residue in the plasma membrane H+-ATPase of Neurospora crassa.
abstract: Treatment of the plasma membrane H+-ATPase of Neurospora crassa with the arginine-specific reagents phenylglyoxal or 2,3-butanedione at 30 degrees C, pH 7.0, leads to a marked inhibition of ATPase activity. MgATP, the physiological substrate of the enzyme, protects against inactivation. MgADP, a competitive inhibitor of ATPase activity with a measured Ki of 0.11 mM, also protects, yielding calculated KD values of 0.125 and 0.115 mM in the presence of phenylglyoxal and 2,3-butanedione, respectively. The excellent agreement between Ki and KD values makes it likely that MgADP exerts its protective effect by binding to the catalytic site of the enzyme. Loss of activity follows pseudo-first order kinetics with respect to phenylglyoxal and 2,3-butanedione concentration, and double log plots of pseudo-first order rate constants versus reagent concentration yield slopes of 0.999 (phenylglyoxal) and 0.885 (2,3-butanedione), suggesting that the modification of one reactive site/mol of H+-ATPase is sufficient for inactivation. This stoichiometry has been confirmed by direct measurements of the incorporation of [14C]phenylglyoxal. Taken together, the results support the notion that one arginine residue, either located at the catalytic site or shielded by a conformational change upon nucleotide binding, plays an essential role in Neurospora H+-ATPase activity.
authors.forename: J S
authors.initials: JS
authors.lastname: Kasher
authors.forename: K E
authors.initials: KE
authors.lastname: Allen
authors.forename: K
authors.initials: K
authors.lastname: Kasamo
authors.forename: C W
authors.initials: CW
authors.lastname: Slayman
mesh_terms: D001120:Arginine; D001665:Binding Sites; D003931:Diacetyl / Q000494:pharmacology; D007700:Kinetics; D009491:Neurospora / Q000201:enzymology*; D009492:Neurospora crassa / Q000201:enzymology*; D010658:Phenylglyoxal / Q000378:metabolism / Q000494:pharmacology; D011485:Protein Binding; D006180:Proton-Translocating ATPases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012265:Ribonucleotides / Q000494:pharmacology
chemical_list: D012265:Ribonucleotides; D001120:Arginine; D006180:Proton-Translocating ATPases; D003931:Diacetyl; D010658:Phenylglyoxal